Cite
HARVARD Citation
Balasis, M. et al. (n.d.). Robust Patient-Derived Xenografts (PDX) Capture the Disease Fidelity of Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML). Leukemia research. pp. S31-S32. [Online].